Research visual

Health Research

Change in chronic obstructive pulmonary disease complexity and health-related quality of life

Hyland E, Song Y, Cordier T, Gumpina R, Renda A, Mapel D, Cusano D. Change in chronic obstructive pulmonary disease complexity and health-related quality of life. Poster presented at CHEST 2017. October 28 - November 02, 2017. Toronto, Canada.

http://apps.humana.com/marketing/documents.asp?file=3267940

COPD exacerbations associated with the modified medical research council scale and COPD assessment test among Humana’s medicare members

Pasquale MK, Xu Y, Baker CL, Zou KH, Teeter JG, Renda AM, Davis CC, Lee TC, Bobula J. COPD exacerbations associated with the modified medical research council scale and COPD assessment test among Humana’s medicare members. International Journal of COPD 2016; 11:111-121.

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4716734/pdf/copd-11-111.pdf

Impact of roflumilast on COPD exacerbations, healthcare utilization and costs in a Medicare Advantage population

Ellis J, Sun SX, Moll K, et al. Impact of roflumilast on COPD exacerbations, healthcare utilization and costs in a Medicare Advantage population. Poster presentation at: American Thoracic Society International Conference. May 16-21, 2014; San Diego, CA.

http://apps.humana.com/marketing/documents.asp?file=2574234

Identification of undiagnosed COPD patients in a claims database using a predictive model

Saverno KR, Zhou Y, Moretz C, Renda A, Burslem K, Jain G, Hernandez G, Dhamane A. Identification of undiagnosed COPD patients in a claims database using a predictive model. Poster presentation at: Academy of Managed Care Pharmacy 26th Annual Scientific Meeting and Expo. April 1-4, 2014; Tampa, FL.

http://apps.humana.com/marketing/documents.asp?file=2332005

COPD-related exacerbation patterns and association with healthcare resource utilization and costs: a retrospective cohort study using an administrative claims database

Saverno K, Zhou Y, Moretz C, Renda A, et al. COPD-related exacerbation patterns and association with healthcare resource utilization and costs: a retrospective cohort study using an administrative claims database. Poster presentation at: Academy of Managed Care Pharmacy 26th Annual Meeting and Expo. April 1-4, 2014; Tampa, FL.

http://apps.humana.com/marketing/documents.asp?file=2331992

Claims-based algorithm targeting Medicare Advantage Prescription Drug (MAPD) members with chronic obstructive pulmonary disease (COPD) for care intervention

Worley K, Shenolikar R, Song F, et al.  Claims-based algorithm targeting Medicare Advantage Prescription Drug (MAPD) members with chronic obstructive pulmonary disease (COPD) for care intervention. Poster presentation at: American Society of Health Systems Pharmacists Midyear Clinical Meeting; December 4-8, 2011; New Orleans, LA.

http://apps.humana.com/marketing/documents.asp?file=2573883

Exacerbations in chronic obstructive pulmonary disease patients from a predominantly Medicare population

Hartnett H.  Exacerbations in chronic obstructive pulmonary disease patients from a predominantly Medicare population. Podium presentation at: V World Asthma & COPD Forum. April, 2012; New York, NY.

Healthcare utilization and costs associated with COPD patients from a predominantly Medicare population

Pasquale M.  Healthcare utilization and costs associated with COPD patients from a predominantly Medicare population.  Podium presentation at:  V World Asthma & COPD Forum. April, 2012; New York, NY.

Impact of exacerbations on health care cost and resource utilization in chronic obstructive pulmonary disease patients with chronic bronchitis from a predominantly Medicare population

Pasquale MK, Sun SX, Song F, Hartnett HJ, Stemkowski SA. Impact of exacerbations on health care cost and resource utilization in chronic obstructive pulmonary disease patients with chronic bronchitis from a predominantly Medicare population. Int J Chron Obstruct Pulmon Dis. 2012;7:757-64. doi:10.2147/COPD.S36887.

Impact of exacerbations on health care cost and resource utilization in chronic obstructive pulmonary disease patients w…

Change in chronic obstructive pulmonary disease complexity and health-related quality of life

Hyland E, Song Y, Cordier T, Gumpina R, Renda A, Mapel D, Cusano D. Change in chronic obstructive pulmonary disease complexity and health-related quality of life. Poster presented at CHEST 2017. October 28 - November 02, 2017. Toronto, Canada.

http://apps.humana.com/marketing/documents.asp?file=3267940

COPD exacerbations associated with the modified medical research council scale and COPD assessment test among Humana’s medicare members

Pasquale MK, Xu Y, Baker CL, Zou KH, Teeter JG, Renda AM, Davis CC, Lee TC, Bobula J. COPD exacerbations associated with the modified medical research council scale and COPD assessment test among Humana’s medicare members. International Journal of COPD 2016; 11:111-121.

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4716734/pdf/copd-11-111.pdf

Impact of roflumilast on COPD exacerbations, healthcare utilization and costs in a Medicare Advantage population

Ellis J, Sun SX, Moll K, et al. Impact of roflumilast on COPD exacerbations, healthcare utilization and costs in a Medicare Advantage population. Poster presentation at: American Thoracic Society International Conference. May 16-21, 2014; San Diego, CA.

http://apps.humana.com/marketing/documents.asp?file=2574234

Identification of undiagnosed COPD patients in a claims database using a predictive model

Saverno KR, Zhou Y, Moretz C, Renda A, Burslem K, Jain G, Hernandez G, Dhamane A. Identification of undiagnosed COPD patients in a claims database using a predictive model. Poster presentation at: Academy of Managed Care Pharmacy 26th Annual Scientific Meeting and Expo. April 1-4, 2014; Tampa, FL.

http://apps.humana.com/marketing/documents.asp?file=2332005

COPD-related exacerbation patterns and association with healthcare resource utilization and costs: a retrospective cohort study using an administrative claims database

Saverno K, Zhou Y, Moretz C, Renda A, et al. COPD-related exacerbation patterns and association with healthcare resource utilization and costs: a retrospective cohort study using an administrative claims database. Poster presentation at: Academy of Managed Care Pharmacy 26th Annual Meeting and Expo. April 1-4, 2014; Tampa, FL.

http://apps.humana.com/marketing/documents.asp?file=2331992

Claims-based algorithm targeting Medicare Advantage Prescription Drug (MAPD) members with chronic obstructive pulmonary disease (COPD) for care intervention

Worley K, Shenolikar R, Song F, et al.  Claims-based algorithm targeting Medicare Advantage Prescription Drug (MAPD) members with chronic obstructive pulmonary disease (COPD) for care intervention. Poster presentation at: American Society of Health Systems Pharmacists Midyear Clinical Meeting; December 4-8, 2011; New Orleans, LA.

http://apps.humana.com/marketing/documents.asp?file=2573883

Exacerbations in chronic obstructive pulmonary disease patients from a predominantly Medicare population

Hartnett H.  Exacerbations in chronic obstructive pulmonary disease patients from a predominantly Medicare population. Podium presentation at: V World Asthma & COPD Forum. April, 2012; New York, NY.

Healthcare utilization and costs associated with COPD patients from a predominantly Medicare population

Pasquale M.  Healthcare utilization and costs associated with COPD patients from a predominantly Medicare population.  Podium presentation at:  V World Asthma & COPD Forum. April, 2012; New York, NY.

Impact of exacerbations on health care cost and resource utilization in chronic obstructive pulmonary disease patients with chronic bronchitis from a predominantly Medicare population

Pasquale MK, Sun SX, Song F, Hartnett HJ, Stemkowski SA. Impact of exacerbations on health care cost and resource utilization in chronic obstructive pulmonary disease patients with chronic bronchitis from a predominantly Medicare population. Int J Chron Obstruct Pulmon Dis. 2012;7:757-64. doi:10.2147/COPD.S36887.

Impact of exacerbations on health care cost and resource utilization in chronic obstructive pulmonary disease patients w…